Pfizer looked into a GSK buyout, FT says; Regulus plots hep C combo study;

@FierceBiotech: ICYMI yesterday: Merck KGaA inks cancer metabolism drug discovery alliance with Selvita. Article | Follow @FierceBiotech

@JohnCFierce: Gates, Hopp back $110M megaround for CureVac's mRNA work. News | Follow @JohnCFierce

@DamianFierce: Wait can we reconvene Grantland just to deal with this image? More | Follow @DamianFierce

> Before taking up buyout talks with Allergan ($AGN), Pfizer ($PFE) made an overture at GlaxoSmithKline ($GSK), according to the Financial Times. Story

> Regulus Therapeutics ($RGLS) and partner GlaxoSmithKline are planning a Phase II study combining their respective hepatitis C therapies RG-101 and GSK2878175. News

> Viking Therapeutics ($VKTX) launched a Phase II study of the bone-boosting VK5211 in patients who recently suffered hip fractures. More

Medical Device News

@FierceMedDev: ICYMI: Drug-device combo from Wyss takes a new approach on treating stroke. FierceBiotechResearch story | Follow @FierceMedDev

@EmilyWFierce: Flowonix teams with Connecticut provider for implant of drug delivery infusion pump. Article | Follow @EmilyWFierce

> Neuromodulator and artificial kidney to be reviewed under FDA's Expedited Access Pathway. More

> Fractyl gains traction with balloon ablation device for Type 2 diabetes. Article

Pharma News

@FiercePharma: ICYMI yesterday: FDA cites Pfizer for shortfalls at Chinese manufacturing plant. Article | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Express Scripts looks into pharmacies at AbbVie, Teva in wake of Valeant's Philidor saga. Article | Follow @CarlyHFierce

> In snit over supply, not prices, MSF urges South Africa to override AbbVie drug patent. Article

> Pfizer flirted with a GSK megabid, but got rejected: FT. Story

Drug Delivery News

> Amgen's Imlygic becomes first re-engineered virus to earn FDA approval as a cancer fighter. Item

> Pfizer's sickle cell anemia candidate enters trials, to the delight of delivery partner Halozyme. Story

> Imaging nanoparticle puts the heat to ovarian cancer cells. Article

> Investigational drug enables faster absorption of bioresorbable drug-eluting stents. Report

> Novartis' inhaler for COPD gets FDA approval. More

Pharma Manufacturing News

> Bain-backed compounding upstart adds second Texas manufacturing facility. Item

> Struggling Daiichi again stumbles with vaccine production. More

> First prefab biologics plant goes up in China, in 11 days. Report

> Roche completes Shanghai plant expansion, starts on new project. Story

> FDA uncovers issues at Pfizer China plant after banning products from its JV partner. Article

Pharma Asia News

> China State Council briefing outlines multilevel system for medical treatment. More

> MabSpace gets $15M as Lilly Asian Ventures bets on immune approach. Story

> China's WuXi PharmaTech, Gilead focus on analytical testing in wider partnership. Article

> HK-based Chi-Med wraps up PhI healthy volunteer trial of HMPL 523. More

> China's Biomab Holding, India's Cipla go separate ways on biosimilars. Report

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.